RINALIX TABLET 2.5 mg

Country: Singapura

Bahasa: Inggeris

Sumber: HSA (Health Sciences Authority)

Beli sekarang

Download Ciri produk (SPC)
21-02-2022

Bahan aktif:

INDAPAMIDE

Boleh didapati daripada:

APEX PHARMA MARKETING PTE. LTD.

Kod ATC:

C03BA11

Dos:

2.5 mg

Borang farmaseutikal:

TABLET, FILM COATED

Komposisi:

INDAPAMIDE 2.5 mg

Laluan pentadbiran:

ORAL

Jenis preskripsi:

Prescription Only

Dikeluarkan oleh:

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Status kebenaran:

ACTIVE

Tarikh kebenaran:

2001-09-13

Ciri produk

                                002
_Choroidal Effusion, Acute Myopia, and Secondary Angle-Closure _
_Glaucoma: _
Sulfonamide
or
sulfonamide
derivative
drugs
can
cause an idiosyncratic reaction resulting in choroidal effusion
with visual field defect, transient myopia and acute angle-closure
glaucoma. Symptoms may include acute onset of decreased
visual acuity or ocular pain and typically occur within hours to
weeks of drug initiation. Untreated acute angle-closure glaucoma
can lead to permanent vision loss. The primary treatment is to
discontinue drug intake as rapidly as possible. Prompt medical or
surgical treatments may need to be considered if the intraocular
pressure remains uncontrolled. Risk factors for developing acute
angle-closure glaucoma may include a history of sulfonamide or
penicillin allergy.
Eye disorders: Choidal effusion (_frequency not known_), acute
angle-closure
glaucoma
(_frequency _
_not _
_known_),
myopia
(_frequency not known_)
15-Dec-2021
12.21
                                
                                Baca dokumen lengkap
                                
                            

Cari amaran yang berkaitan dengan produk ini